NCT07089095 Factors and Preferences in Patient Selection of Rehabilitation Care Following Acute Stroke: A Predictive Correlational Study.
| NCT ID | NCT07089095 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Acute Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-05-11 |
| Primary Completion | 2025-07-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2023-05-11 with a primary completion date of 2025-07-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background and Purpose Patients with stroke have to receive the rehabilitation care after medical condition has stabilized. In recent years, the long-term care policy offers more options available for rehabilitation care after stroke. However, the selection of care is mainly based on physcicians' advice. This study explores the factors and preferences in patient selection of rehabilitation care following acute stroke, in order to help clinical health professionals incorporate patients' preferences in patient-centred care to properly arrange the stroke rehabilitation care. Methods This is a cross-sectional and predictive study. Purposive sampling of patients surviving acute stroke is taken in the general ward of a medical center in northern Taiwan. Data are collected with patients' characteristics, National Institutes of Health Stroke Scale (NIHSS), Barthel Index (BI), Modified Rankin Scale (mRS), and factors and preferences in patient selection of rehabilitation care questionnaire. Data are analyzed using IBM SPSS 26.0 for windows. Demographic and clinical characteristics, family support systems and health care systems are compared between patients' preference in the selections of rehabilitation care. Variables with p \< .05 are included as potential predictor variables in the subsequent logistic regression analysis. The level of statistical significance is set at α=0.05. Expected results Demographic and clinical characteristics, family support systems and health care systems are expected as potential predictors of patients' preference in the selection of rehabilitation care.
Eligibility Criteria
Inclusion Criteria: * Age≧18 years old. * Patients with stroke (International Classification of Disease, ICD 10th edition I60-I68, G45-G46) diagnosed by physicians within 2 weeks after the onset of stroke, including the first and second strokes. Exclusion Criteria: * Those with a score of 5 on the Modified Rankin Scale (mRS). * Those who have been accepted as research subjects have been admitted to hospital again for stroke. * People living in rehabilitation wards. * Those with unstable vital signs. * Those receiving palliative care or care. * Patients or family members who cannot communicate in Chinese or Taiwanese.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07089095 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07089095 currently recruiting?
Yes, NCT07089095 is actively recruiting participants. Contact the research team at tracy109488@gmail.com for enrollment information.
Where is the NCT07089095 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07089095 clinical trial?
NCT07089095 is sponsored by National Taiwan University Hospital. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.